Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

102 III. SUBSTANCES OF ABUSEet al. (1999). Response to nicotine dependence treatment in smokers with currentand past alcohol problems. Ann Behav Med, 21, 244–250.Helzer, J. E., & Pryzbeck, T. R. (1988). The co-occurrence of alcoholism with other psychiatricdisorders in the general population and its impact on treatment. J StudAlcohol, 49(3), 219–224.Hermann, D., Heinz, A., & Mann, K. (2002). Dysregulation of the hypothalamice–pituitary–thyroid axis in alcoholism. Addiction, 97(11), 1369–1381.Higgins, E. M., & du Vivier, A. W. P. (1992). Alcohol and the skin. Alcohol, 27, 595–602.Howard, M. O., Kivlahan, D., & Walker, R. D. (1997). Cloninger’s tri-dimensional theoryof personality and psychopathology: Applications to substance use disorders. JStud Alcohol, 58, 48–66.Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg J., & AnthonyJ. C. (1997). Lifetime co occurrence of DSM-III-R alcohol abuse and dependencewith other psychiatric disorders in the National Comorbidity Survey. Arch GenPsychiatry, 54, 313–321.Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., etal. (1994). Lifetime and 12 month prevalence of DSM-III-R psychiatric disordersin the United States. Arch Gen Psychiatry, 51, 8–19.Klatsky, A. L., Friedman, G. D., & Armstrong, M. A. (1986). Relationships betweenalcoholic beverage use and other traits to blood pressure: A new KaiserPermanente study. Circulation, 73(4),628–636.Koenigsberg, H. W., Kaplan, R. D., Gilmore, M. M., & Cooper, A. M. (1985). The relationshipbetween syndrome and personality disorder in DSM-III: Experience with2,462 patients. Am J Psychiatry, 142(2), 207–212.Laitinen, K., Karkkainen, M., Lalla, M., Lamberg-Allardt, C., Tunninen, R., Tahtela,R., & Volamaki, M. (1993). Is alcohol an osteoporosis-inducing agent for youngand middle-aged women? Metabolism, 42, 875–881.Latif, O., Peterson, J. D., & Waltenbaugh, C. (2002). Alcohol-mediated polarization oftype I and type II immune responses. Front Biosci, 7, 135–147.Lee, G. R. (1999). Folate deficiency: Causes and management. In G. R. Lee, J. Foerster,J. Lukens, F. Paraskeras, J. Greer, & G. Rodgers (Eds.), Wintrole’s clinical hematology(10th ed., pp. 965–972). Baltimore: Williams & Wilkins.Lee, W. K., & Regan, T. J. (2002). Alcoholic cardiomyopathy: Is it dose dependent?Congest Heart Fail, 8(6), 303–306, 312.Lieber, C. S. (1998). Hepatic and other medical disorders of alcoholism: From pathogenesisto treatment. J Stud Alcohol, 59(1), 9–25.Luczak, S. E., Wall, T. L., Shea, S. H., Byun, S. M., & Carr, L. G. (2001). Binge drinkingin Chinese, Korea, and White college students: Genetic and ethnic group differences.Psychol Addict Behav, 15, 306–309.May, P., & Gossage, J. (2001). The epidemiology of alcohol consumption among AmericanIndians living on four reservations and in nearby border towns. Drug AlcoholDepend, 63(Suppl 1), S100.McEvoy, J. P. (1982). The chronic neuropsychiatric disorders associated with alcohol.In E. M. Pattison & E. Kauknan (Eds.), Encyclopedic handbook of alcoholism(pp.167–179). New York: Gardner Press.Midanik, L. T., Tam, T. W., Greenfield, T. K., & Caetano, R. (1996). Risk functions